Are autoimmune diseases predictable?

Shapira, 2010, Geoepidemiology of autoimmune rheumatic diseases, Nat Rev Rheumatol, 6, 468, 10.1038/nrrheum.2010.86 Youinou, 2010, Geo-epidemiology and autoimmunity, J Autoimmun, 34, 163, 10.1016/j.jaut.2009.12.005 Lleo, 2010, Definition of human autoimmunity—autoantibodies versus autoimmune disease, Autoimmun Rev, 9, A259, 10.1016/j.autrev.2009.12.002 Deane, 2010, Preclinical rheumatoid arthritis: identification, evaluation, and future directions for investigation, Rheum Dis Clin North Am, 36, 213, 10.1016/j.rdc.2010.02.001 Arbuckle, 2003, Development of autoantibodies before the clinical onset of systemic lupus erythematosus, N Engl J Med, 349, 1526, 10.1056/NEJMoa021933 Eriksson, 2011, Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden, Arthritis Res Ther, 13, R30, 10.1186/ar3258 Heinlen, 2010, Ribosomal P autoantibodies are present before SLE onset and are directed against non-C-terminal peptides, J Mol Med, 88, 719, 10.1007/s00109-010-0618-1 del Puente, 1988, The incidence of rheumatoid arthritis is predicted by rheumatoid factor titer in a longitudinal population study, Arthritis Rheum, 31, 1239, 10.1002/art.1780311004 Aho, 1991, Rheumatoid factors antedating clinical rheumatoid arthritis, J Rheumatol, 18, 1282 Kurki, 1992, Immunopathology of rheumatoid arthritis, antikeratin antibodies precede the clinical disease, Arthritis Rheum, 35, 914, 10.1002/art.1780350810 Aho, 1993, Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process, J Rheumatol, 20, 1278 Aho, 1997, Serum immunoglobulins and the risk of rheumatoid arthritis, Ann Rheum Dis, 56, 351, 10.1136/ard.56.6.351 Isermann, 2007, Autoantibodies in diabetes mellitus: current utility and perspectives, Exp Clin Endocrinol Diabetes, 115, 483, 10.1055/s-2007-981452 Rantapaa-Dahlqvist, 2003, Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis, Arthritis Rheum, 48, 2741, 10.1002/art.11223 Nielen, 2004, Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors, Arthritis Rheum, 50, 380, 10.1002/art.20018 Majka, 2008, Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis, Ann Rheum Dis, 67, 801, 10.1136/ard.2007.076679 Beyan, 2010, Monocyte gene-expression profiles associated with childhood-onset type 1 diabetes and disease risk: a study of identical twins, Diabetes, 59, 1751, 10.2337/db09-1433 Oling, 2010, A low antigen dose selectively promotes expansion of high-avidity autoreactive T cells with distinct phenotypic characteristics: a study of human autoreactive CD4+ T cells specific for GAD65, Autoimmunity, 43, 573, 10.3109/08916930903540424 Rasche, 2009, GAD65-specific cytotoxic T lymphocytes mediate beta-cell death and loss of function, Rev Diabet Stud, 6, 43, 10.1900/RDS.2009.6.43 Collins, 2006, The application of genomic and proteomic technologies in predictive, preventive and personalized medicine, Vascul Pharmacol, 45, 258, 10.1016/j.vph.2006.08.003 Nicodemus, 2008, Catmap: case–control and TDT meta-analysis package, BMC Bioinformatics, 28, 130, 10.1186/1471-2105-9-130 Rosati, 2001, The prevalence of multiple sclerosis in the world: an update, Neurol Sci, 22, 117, 10.1007/s100720170011 Vehik, 2011, The changing epidemiology of type 1 diabetes: why is it going through the roof?, Diabetes Metab Res Rev, 27, 3, 10.1002/dmrr.1141 Maahs, 2010, Epidemiology of type 1 diabetes, Endocrinol Metab Clin North Am, 39, 481, 10.1016/j.ecl.2010.05.011 Songini, 2010, The Sardinian way to type 1 diabetes, J Diabetes Sci Technol, 4, 1248, 10.1177/193229681000400526 Molokhia, 2006, Systemic lupus erythematosus: genes versus environment in high risk populations, Lupus, 15, 827, 10.1177/0961203306070007 Patel, 2006, The prevalence and incidence of biopsy-proven lupus nephritis in the UK: evidence of an ethnic gradient, Arthritis Rheum, 54, 2963, 10.1002/art.22079 Ballestar, 2010, Epigenetics lessons from twins: prospects for autoimmune disease, Clin Rev Allergy Immunol, 39, 30, 10.1007/s12016-009-8168-4 Selmi, 2004, Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment, Gastroenterology, 127, 485, 10.1053/j.gastro.2004.05.005 Fong, 2010, Neuropsychiatric lupus: clinical challenges, brain-reactive autoantibodies and treatment strategies, Lupus, 19, 1399, 10.1177/0961203310374338 Hernández-Molina, 2011, The meaning of anti-Ro and anti-La antibodies in primary Sjögren's syndrome, Autoimmun Rev, 10, 123, 10.1016/j.autrev.2010.09.001 Alaedini, 2008, Autoantibodies in celiac disease, Autoimmunity, 41, 19, 10.1080/08916930701619219 Carp, 2008, Autoantibodies as predictors of pregnancy complications, Rheumatology (Oxford), 47, iii6, 10.1093/rheumatology/ken154 Doria, 2008, Preventive strategies in systemic lupus erythematosus, Autoimmun Rev, 7, 192, 10.1016/j.autrev.2007.11.004 Klareskog, 2010, Prevention of autoimmune rheumatic disease: state of the art and future perspectives, Ann Rheum Dis, 69, 2062, 10.1136/ard.2010.142109 Atkinson, 2004, Thirty years of investigating the autoimmune basis for type 1 diabetes: why can't we prevent or reverse this disease?, Diabetes, 54, 1253 Fagan, 1975, Letter: Nomogram for Bayes theorem, N Engl J Med, 293, 257, 10.1056/NEJM197507312930513 Hellmich, 2005, A ruler for interpreting diagnostic test results, Methods Inf Med, 44, 124, 10.1055/s-0038-1633930 Silman, 1992, Incidence of rheumatoid arthritis in a genetically predisposed population, Br J Rheumatol, 31, 365, 10.1093/rheumatology/31.6.365 Walker, 1986, Rheumatoid factor tests in the diagnosis and prediction of rheumatoid arthritis, Ann Rheum Dis, 45, 684, 10.1136/ard.45.8.684 Halldorsdottir, 2000, A prospective study on the incidence of rheumatoid arthritis among people with persistent increase of rheumatoid factor, Ann Rheum Dis, 59, 149, 10.1136/ard.59.2.149 Kokkonen, 2011, Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis, Arthritis Res Ther, 3, R13, 10.1186/ar3237 Bonifacio, 1995, Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity, Diabetologia, 38, 816, 10.1007/s001250050358 Zhang, 2011, Prediction and prevention of type 1 diabetes mellitus, J Diabetes, 3, 48, 10.1111/j.1753-0407.2010.00102.x Andersson, 2011, The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes, Autoimmunity, 44, 394, 10.3109/08916934.2010.540604 Yang, 2010, The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese, Diabetes Metab Res Rev, 26, 579, 10.1002/dmrr.1128 Mrena, 2006, Models for predicting type 1 diabetes in siblings of affected children, Diabetes Care, 29, 662, 10.2337/diacare.29.03.06.dc05-0774 LaGasse, 2002, Washington State diabetes prediction study, successful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies: an 8-year follow-up of the Washington State diabetes prediction study, Diabetes Care, 25, 505, 10.2337/diacare.25.3.505 Kupila, 2001, Juvenile Diabetes Research Foundation Centre for the Prevention of Type I Diabetes in Finland. Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort, Diabetologia, 44, 290, 10.1007/s001250051616 Barker, 2004, Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY), J Clin Endocrinol Metab, 89, 3896, 10.1210/jc.2003-031887 Bizzaro, 2007, Autoantibodies as predictors of disease: the clinical and experimental evidence, Autoimmun Rev, 6, 325, 10.1016/j.autrev.2007.01.006 Frenzel, 2006, Evaluation of F-actin ELISA for the diagnosis of autoimmune hepatitis, Am J Gastroenterol, 101, 2731, 10.1111/j.1572-0241.2006.00830.x Betterle, 2011, Autoimmune Addison's disease, Endocr Dev, 20, 161, 10.1159/000321239 Caforio, 2002, Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance, Eur J Heart Fail, 4, 411, 10.1016/S1388-9842(02)00010-7 Israeli, 2005, Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease, Gut, 54, 1232, 10.1136/gut.2004.060228 Deng, 2010, Genetic susceptibility to systemic lupus erythematosus in the genomic era, Nat Rev Rheumatol, 6, 683, 10.1038/nrrheum.2010.176 Trynka, 2010, A genetic perspective on coeliac disease, Trends Mol Med, 16, 537, 10.1016/j.molmed.2010.09.003 Gregersen, 2009, Recent advances in the genetics of autoimmune disease, Annu Rev Immunol, 27, 363, 10.1146/annurev.immunol.021908.132653 Kolfenbach, 2009, A prospective approach to investigating the natural history of preclinical rheumatoid arthritis (RA) using first-degree relatives of probands with RA, Arthritis Rheum, 61, 1735, 10.1002/art.24833 Anaya, 2010, The autoimmune tautology, Arthritis Res Ther, 12, 147, 10.1186/ar3175 Cifuentes, 2011, Human leukocyte antigen class II and type 1 diabetes in Latin America: a combined meta-analysis of association and family-based studies, Hum Immunol, 15 Rojas-Villarraga, 2010, HLA-class II in Latin American patients with type 1 diabetes, Autoimmun Rev, 9, 666, 10.1016/j.autrev.2010.05.016 Rojas, 2010, HLA class II polymorphism in Latin American patients with multiple sclerosis, Autoimmun Rev, 9, 407, 10.1016/j.autrev.2009.11.001 Duarte-Rey, 2009, HLA class II association with autoimmune hepatitis in Latin America: a meta-analysis, Autoimmun Rev, 8, 325, 10.1016/j.autrev.2008.11.005 Serrano, 2006, Non-HLA associations with autoimmune diseases, Autoimmun Rev, 5, 209, 10.1016/j.autrev.2005.06.009 Pradhan, 2010, PTPN22 gene polymorphisms in autoimmune diseases with special reference to systemic lupus erythematosus disease susceptibility, J Postgrad Med, 56, 239, 10.4103/0022-3859.68651 Burn, 2011, Why is PTPN22 a good candidate susceptibility gene for autoimmune disease?, FEBS Lett, 10.1016/j.febslet.2011.04.032 Jakobsdottir, 2009, Interpretation of genetic association studies: markers with replicated highly significant odds ratios may be poor classifiers, PLoS Genet, 5, e10000337, 10.1371/journal.pgen.1000337 van der Linden, 2009, Association of a single-nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis, Arthritis Rheum, 60, 2242, 10.1002/art.24721 Gregersen, 2009, REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis, Nat Genet, 41, 820, 10.1038/ng.395 Lu, 2009, Genetic associations of LYN with systemic lupus erythematosus, Genes Immun, 10, 397, 10.1038/gene.2009.19 Javierre, 2010, Changes in the pattern of DNA methylation associate with twin discordance in SLE, Genome Res, 20, 170, 10.1101/gr.100289.109 Ballestar, 2011, Epigenetic alterations in autoimmune rheumatic diseases, Nat Rev Rheumatol, 7, 263, 10.1038/nrrheum.2011.16 Richardson, 1990, Evidence for impaired T cell DNA methylation in SLE and rheumatoid arthritis, Arthritis Rheum, 33, 1665, 10.1002/art.1780331109 Kawano, 2011, miR-124a as a key regulator of proliferation and MCP-1 secretion in synoviocytes from patients with rheumatoid arthritis, Ann Rheum Dis, 70, i88, 10.1136/ard.2010.138669 O'Connell, 2010, MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development, Immunity, 29, 607, 10.1016/j.immuni.2010.09.009 Te, 2010, Identification of unique microRNA signature associated with lupus nephritis, PLoS One, 11, e10344, 10.1371/journal.pone.0010344 Li, 2010, Altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis, Arthritis Res Ther, 12, R81, 10.1186/ar3006 Allantaz, 2007, Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade, J Exp Med, 204, 2131, 10.1084/jem.20070070 Binard, 2009, Is the blood B-cell subset profile diagnostic for Sjogren syndrome?, Ann Rheum Dis, 68, 1447, 10.1136/ard.2008.096172 Oresic, 2008, Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes, J Exp Med, 205, 2975, 10.1084/jem.20081800 Shovman, 2005, Multiplexed atheNA multi-lyte immunoassay for ANA screening in autoimmune diseases, Autoimmunity, 38, 105, 10.1080/08916930400022707 Shovman, 2005, Evaluation of the BioPlexTM 2200ANAscreen: analysis of 510 healthy subjects: incidence of natural predictive autoantibodies, Ann N Y Acad Sci, 1050, 280, 10.1196/annals.1313.120 Arom-Maor, 2001, Vaccination and systemic lupus erythematosus: the bidirectional dilemmas, Lupus, 10, 237, 10.1191/096120301673085478 Reifen, 1998, Dietary polyunsaturated fatty acids decrease anti-dsDNA and anti-cardiolipin antibodies production in idiotype induced mouse model of systemic lupus erythematosus, Lupus, 7, 192, 10.1191/096120398678919985 Aronson, 2007, Vitamin D and autoimmunity: etiological and therapeutical considerations, Ann Rheum Dis, 66, 1137, 10.1136/ard.2007.069831